Suélia de Siqueira Rodrigues Fleury Rosa

Suélia de Siqueira Rodrigues Fleury Rosa has a well-established academic and professional career, with recognized leadership in the field of Biomedical Engineering. She holds a degree in Electronic Engineering from São Paulo State University (UNESP, 2003), a Masters in Electronic/Mechatronic Engineering from the Aeronautics Institute of Technology (ITA, 2005), and a Ph.D. in Biomedical Electronic Engineering from the University of Brasília (2008). In 2013, she completed a postdoctoral fellowship at the Media Lab of the Massachusetts Institute of Technology (MIT), with an emphasis on the human-machine interface.She is currently an Associate Professor IV at the University of Brasília (UnB) and is presently on official leave for professional development in higher education internationalization, with ongoing academic activities based in New York, USA.Dr. Fleury Rosa is the founder of three reference laboratories affiliated with UnBs School of Gama (FGA): LEI (Engineering and Innovation Lab), BioEngLab (Biomedical Engineering and Biomaterials Lab), and the Organ-on-a-Chip and Tissue Engineering Research and Innovation Hub (Organ.on.a.chip/UnB). She coordinates interdisciplinary research, development, and innovation (RDI) projects, with strong emphasis on technologies with social impact.Her international engagement and distinctions in scientific societiessuch as the Institute of Electrical and Electronics Engineers (IEEE) and the Brazilian Diabetes Society (SBD)reflect her ability to lead multidisciplinary teams, engage with the innovation ecosystem, and ensure excellence in the execution of strategic projects for national development.She has served as Chair of the IEEE Center-North R9 Latin America Chapter, where she remains an active member and holds the title of Senior Member. She is also affiliated with the Brazilian Society of Biomedical Engineering (SBEB) and the ABCM Committee on Nonlinear and Chaotic Phenomena.Her work focuses on translational health research, with extensive experience in the development of medical devices, preclinical and clinical trials, regulatory certification by the Brazilian Health Regulatory Agency (ANVISA), and technology transfer processes. She conducts research in tissue engineering and alternatives to animal testing, developing Organ-on-a-Chip platforms, microfluidic devices, and bond graphbased in silico simulations for modeling biological systems.She also investigates biomedical applications of biomaterials such as natural latex, photobiomodulation technologies, and treatments for chronic wounds. Her innovations include medical devices targeting hepatocellular carcinoma and cardiac ablation, with strong social and scientific impact, prioritizing low-cost technologies intended for integration into Brazils Unified Health System (SUS).She has extensive experience leading applied research and technological innovation projects, notably within the Research for SUS Program (PPSUS), where she led the development of technologies for treating diabetes-related complications, including the coordination of a randomized clinical trial. Her expertise spans the full pipelinefrom medical device development to clinical validationalways in alignment with regulatory standards. (Source: Lattes Curriculum)